Clinical trials: Hypothalamic Injury-induced Obesity (HIO)

Hypothalamic Injury-induced Obesity (HIO)

48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)

• Completed
• Age: 18 to 75 years
• Phase 2
• Results posted

Double-blind, randomized, placebo-controlled, single- center study followed by an open-label extension period. The study will have two parts: Part 1: 24 weeks double-blind treatment (DB), followed by Part 2: 24 weeks open-label…

Trial name

NCT03845075

Testing

Tesofensine/Metoprolol

Where

Denmark

Volunteers

21 people

Sponsor

Saniona